ExodusPoint Capital Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

ExodusPoint Capital Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,378	Closed	-$42K	–	1851
2022 Q3	$42K	Buy	+10,378	New	+$78.7K	﹤0.01%	1796
2021 Q2	–	Sell	-254,443	Closed	-$12.3M	–	2562
2021 Q1	$12.3M	Buy	254,443 +104,225	+69%	+$5.65M	0.18%	99
2020 Q4	$7.08M	Buy	+150,218	New	+$5.92M	0.07%	179

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ExodusPoint Capital Management's NBP Position: Q4 2022 in Review

ExodusPoint Capital Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2022, closing a stake of 10,378 shares — an estimated $42K sold.

ExodusPoint Capital Management first reported a position in NBP in Q4 2020 and held it in 3 quarters. The position peaked at $12.3M in Q1 2021. 69 funds tracked by Wall St. Rank hold NBP as of Q4 2022.

ExodusPoint Capital Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 10,378 NovaBridge Biosciences American Depositary Shares shares in Q4 2022, an estimated $42K.
ExodusPoint Capital Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 3 quarters.
ExodusPoint Capital Management's NovaBridge Biosciences American Depositary Shares position peaked at $12.3M in Q1 2021.
69 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2022.

Based on ExodusPoint Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.